AK HB373

Requires prescription drug manufacturers and labelers operating in Alaska to report marketing costs to the Department of Health and Social Services by July 1 each year.

Reports must include expenses for direct-to-consumer advertising (radio, television, magazines, newspapers, direct mail, telephone), marketing to health care providers, employee/contractor costs related to marketing, food, entertainment, gifts, travel, and product samples.

Exempts expenses of $25 or less, clinical trial costs, and scholarships or conference attendance reimbursements selected by medical associations.

Department must provide aggregated annual reports to the attorney general and legislature by November 1, and detailed biennial analyses by November 1 every two years examining the scope, cost, and effects of marketing on health care services.

Manufacturers and labelers who knowingly fail to report are subject to a $1,000 civil penalty; act takes effect July 1, 2010.